Mangaluru expats among 12 killed in Jubail factory fire; many critical

[email protected] (CD Network)
April 16, 2016

Jubail, Apr 16: At least 12 people were killed and 11 others sustained severe injuries after fire broke out in a petrochemical factory in Saudi Arabia's largest industrial area located east of the Kingdom Satuday.

victims

Among the injured the condition of at least six is said to be extremely critical.

The incident took place in an area that was under construction and during routine maintenance at Jubail United Petrochemical Company plant.

Sources close to the Saudi Royal Commission said that the victims include expatriates from India and other countries.

It is learnt that Indian victims hailed from Karnataka's coastal city of Mangaluru and Kerala.

The fire broke out when technicians of the maintenance contractor were replacing catalysts in the plant.

Due to heavy smoke people suffered suffocation. The condition of the injured is stable said spokesman for the Royal Commission for Jubail and Yanbu Dr. Abdulrahman Al-Abdulqader.

injured

The CEO of the Royal Commission for Jubail and Yanbu Dr. Muslih Al–Otaibi and United Company Chairman Adel Al-Sharidi visited the injured and the accident scene.

The Civil Defense and fire fighters were able to extinguish the fire after 10 minutes of its break out at 11:40 am local time. While the fire was small, it left people with severe smoke inhalation injuries.

Unconfirmed sources have identified the deceased as Bhaskar Bajpe, Vincent Nirmarga, Daniel Kerala, Jolan Filipino (all four in Al Mana Hospital), Ashraf Haleyangadi, lijon Kerala, Balakrishna Poojari Vamanjoor, Mohammed Ibrahim India (all four in Royal Commission Hospital), Karthik Sanil Krishnappa India, Ashish Kumar Singh India and Martin Filipino (all three in Mowasat Hospital).

Among the injured, Dheeraj Manjeshwar Rayan Filipino Athik UP Amrit Nepal and Saeed Kavoor are have been admitted to intensive care units of two different hospitals. The other injured include Nithin Venuru, Yathish Ullal, Ayyub Farangipet and Abhilash Niddodi.

Also Read:

Jubail factory fire leaves families of Mangaluru victims shell-shocked

1victims

visa

1fire

Comments

NOOR
 - 
Sunday, 17 Apr 2016

inna lillahi wa inna ilaihi raajioon
Indeed we belong to ALLAH and indeed to HIM shall we return.
May ALLAH grant jannah & help the family to cope with the situation.

Fahad
 - 
Saturday, 16 Apr 2016

Sushma Swaraj, the external affairs minister of india is on Iran visit. In this situation she must cut short her Iran visit and rush to Saudi Arabia to visit Indian victims.

Nisar
 - 
Saturday, 16 Apr 2016

A shocking incident. Do not know how to console aggrieved families. All lower middle class expats.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 16,2020

University of Oxford researchers have claimed that a cheap and widely available drug called dexamethasone can help save the lives of patients who are seriously ill with coronavirus.

Scientists working on the Recovery Trial found the drug could help patients on ventilators and oxygen, but had no effect on those who did not need help breathing.

“Based on these results, one death would be prevented by treatment of around eight ventilated patients or around 25 patients requiring oxygen alone,” researchers said in a statement.

Matt Hancock, the health secretary, tweeted: “This global first exemplifies the power of science.”

“I’m absolutely delighted that today we can announce the first successful clinical trial for a treatment for Covid-19,” Mr Hancock said.

Recovery Trial experts said a randomised group of 2,104 patients was given 6mg of dexamethasone per day for 10 days, while another group of 4,321 were given normal treatment.

Dexamethasone reduced deaths by one-fifth in patients on oxygen feeds and by one-third in those who needed a ventilator to breathe, preliminary results showed.

Mr Hancock added: “This is a huge step forward and it’s because we’ve backed the science.”

Martin Landray, professor of medicine and epidemiology at the Nuffield Department of Population Health, University of Oxford, and one of the trial’s chief investigators, said in a statement: “These preliminary results from the Recovery Trial are very clear – dexamethasone reduces the risk of death among patients with severe respiratory complications.

“Covid-19 is a global disease – it is fantastic that the first treatment demonstrated to reduce mortality is one that is instantly available and affordable worldwide.”

Comments

kushal kumar
 - 
Thursday, 18 Jun 2020

Trials  of  drug  dexamethasone   in  Covid-19  cases   have  brought  success  in  saving  lives  ,  claim  Oxford  University  scientists  on  16 June  2020. 

              According  to  news  reports  on  16 June  , 2020  ,   Oxford  University  Scientists  have  conducted  trials  on  anti-inflammatory  steroid  Dexamethasone   in  Covid-19  cases.  Results  released  by  the   Oxford  University    on  16  June  2020  say  that  the   low-cost  and  easily  available  drug  saves  the  people  seriously  infected  by   Coronavirus  ,  cuts  the  death  risk  by  a  third  for  those  on  ventilators  and  by  a  fifth  for  those  on  oxygen.  The  commentary   on  the  drug   reads  like  this  :-

“  This  is  a  tremendous  news  today  from  the  recovery  trial  showing  that  dexamethasone   is  the  first  drug  to  reduce  mortality  from  Covid-19.  It  is  particularly  exciting  as  this  is  an  inexpensive  widely  available  medicine.  This  is  a  ground  breaking  development  in  our  fight  against  the  disease  and  the  speed  at  which  researchers  have  progressed  finding  an  effective  treatment  ,  is  truly  remarkable.  It  shows  importance  of  doing  high  quality  clinical  trials  and  basing  decisions  as  the  results  of  those  trials”. 

               Covid-19  has  taken  into  its  grip   the  entire  world  during  first  half  of  the  year  2020  ,  infecting   lacs  and  killing  also  lacs  of   its  patients.  In  the  absence  of  an  effective  drug  or  vaccine  ,  people  had  no  choice  other  than   to   look   up   to  the  heavens  or   scientists  to  come  with  some  cure.  And  the  drug  described  here  is  the  first  one  to  respond  to  the  prayer   of  the  global  community  ,  it  seems.     As  regards  a  vaccine  ,   only  few  are  claiming  that  it  can  come  by  the  end  of  the  present  year  2020.  Rather   ,  some  are  of  the  view  that  it  may  take  a  larger  part  of  the  year  2021  and   could   even  go    to  mid-2022.   Whatever  that  scenario  about  prospect  of  arrival  of  vaccine  to  treat  Covid-19  may  be   ,  the  news  that  was  broken   on  16  June  2020   by   the  Oxford  University   scientists   in  relation  to   drug  dexamethasone   would  have  sent  a  wave  of   strength  and  hope   among   people  world-wide.  And  this  Vedic  astrology  writer  was  spirited  for  another  reason  as   well   -  a  prediction  of   when  some  relief   by  way  of  drug  to  fight  Covid-19   may  appear  ,   having  come  accurate  in   the   claim  announced  by  Oxford  University   on  16 June  2020.  This  writer  had  ,   based   on  interpretation  and  application   of  Vedic  astrology  ,   contributed  in  early  April  ,  2020   an  opinion  piece     - “  Some  searchlight  on  way  out  of  Covid-19  presently  tormenting  mankind” -   to  a  number  of   newspapers.  It  was  also  contributed  on  11  April  ,  2020   using  the  ‘ comments’   column  of  article  -‘ Heard  Charles  took   Ayurveda  treatment-based  Ayush  drugs  for   Covid-19’  -   at   theprint.in/india/looking-at-evidence-based-ayush-medicines-to-treat-covid-19-minister-shripad-naik/393407/.   The  text  in  the  opinion  piece  related  to  the  claim  of  success  announced  by  Oxford  University  scientists  on  16 June  ,  2020  ,  reads  like  this  :- 

“  So  reading  in  between  the  lines  ,  it  can  be  said  that  some  effective  drug   or  remedy  can  arrive  by   mid   or  towards   the  last  week  of  June  2020   to   provide  some  relief  during  July  to  September  2020 ,  to  some  good  extent”.

The  point  this  writer  wants  to  share  with  readers  world-wide  is  that   yes  ,  a  drug   envisaged  in  the  aforesaid  prediction  has  appeared  on  the  horizon  in  the  claim  announcement  of  Oxord  University  scientists  on  16  June ,  2020. 

Bio  :-

 

Kushal  kumar  ,

202-GH28  ,  Mansarovar   Apartments  ,

Sector  20  ,  Panchkula-134116  ,  Haryana,

India.

Note  :-  This  writer’s    significant  predictive  work  covering   2020   about   the  U.S.  and  Italy

 

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com news network
June 25,2020

Mangaluru, Jun 25: In a shocking development, as many as five post-graduate (PG) doctors have tested positive for coronavirus in Mangaluru. 

The one male and four female doctors – all aged around 28 years – are asymptomatic and are being treated at the designated covid hospital in the city.

All the five PG doctors of Kasturba Medical College were deputed at Govt. Lady Goschen Hospital and District Wenlock Hospital (Covid Hospital).

Meanwhile, around 30 medicos have been quarantined.

According to sources, the five doctors were staying in a residential apartment in the city. The apartment is likely to be sealed.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 8,2020

Bengaluru, Mar 8: Lieutenant General Milind Hemant Thakur, Director-General of Supply and Transport Corps of the Indian Army, unveiled the renovated Animal Memorial at Agram Grounds in ASC Centre and College here on Saturday.

The animal memorial signifies the contributions of mules and horses of the Indian Army. These animals belonging to the Army Service Corps, who have rendered their services relentlessly during the war in the Himalayas, often paying the highest price of sacrificing their lives in the line of duty have been chronicled in the Memorial.

To ensure that these hoof prints do not get obliterated, on approval by the Government of India, their saga was brought to life in the form of a sculptured monument in the Equestrian Training Area of the ASC Centre and College.

This animal transport memorial has now been extended by constructing two walls supported by Roman pillars on either side.

These walls highlight the role played by the animals in the Indian Army since the British Raj. It gives details of 637 gallantry awards won by the brave muleteers, 49 battle casualties since independence, 14 gallantry awards to mules since independence and 05 military recognitions bestowed by the Chief of the Army Staff and other Army Commanders on AT units, who have been relied upon heavily to fill an important niche in the logistics networks of the Indian Army.

Gen Thakur also declared that 26 September each year has been nominated as the AT Remembrance Day as it was on this day in 1914, that 9th mule Corps, as part of the Indian Expeditionary Force, landed at Marseilles in France, to a most hearty and enthusiastic welcome by the French to support the British and allied armies in World War One.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.